Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII•United States

Financial Services United States Shell Companies

Need professional-grade analysis? Visit stockanalysis.com

$10.01

+0.00%

End of day

Market Cap

$652.47M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	1.62	—	—	—	1.62
Sharpe	—	2.20	1.13	—	—	—	1.56
Omega	—	1.75	1.32	—	—	—	1.49
Martin	—	—	9.08	—	—	—	9.08
Ulcer	—	0.06	0.27	—	—	—	0.18

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Price Performance

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) trades on United States in USD. The company is classified in the Financial Services sector under the Shell Companies industry. The stock currently trades at $10.01.

Over the past year, DMII has traded between a low of $9.87 and a high of $10.01. The stock has gained 1.3% over this period.

Drugs Made In America Acquisition II Corp. Ordinary Shares has a market capitalization of $652.47M.

About Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Company Info

Sector: Financial Services
Industry: Shell Companies
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: $-151,719
Profit Margin: N/A
EPS (TTM): N/A
Book Value: -0.26

Technical Indicators

52 Week High: $10.01
52 Week Low: N/A
50 Day MA: $9.96
200 Day MA: $9.94
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: $652.76M